PTJ
QTTB icon

Paul Tudor Jones’s Q32 Bio QTTB Stock Holding History

Paul Tudor Jones’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,424
Closed -$70.3K – 2873
2023
Q4 		$70.3K Hold
6,424
– – ﹤0.01% 2257
2023
Q3 		$135K Hold
6,424
– – ﹤0.01% 2130
2023
Q2 		$102K Hold
6,424
– – ﹤0.01% 2293
2023
Q1 		$119K Hold
6,424
– – ﹤0.01% 2244
2022
Q4 		$146K Hold
6,424
– – ﹤0.01% 2182
2022
Q3 		$186K Sell
6,424
-33
-0.5% -$1.35K ﹤0.01% 2094
2022
Q2 		$229K Sell
6,457
-1,445
-18% -$49.3K 0.01% 1731
2022
Q1 		$432K Buy
7,902
+5,028
+175% +$312K 0.01% 1356
2021
Q4 		$188K Buy
+2,874
New +$279K ﹤0.01% 2182
2021
Q3 		– Sell
-7,178
Closed -$939K – 2865
2021
Q2 		$939K Buy
+7,178
New +$896K 0.02% 893
2021
Q1 		– Sell
-3,240
Closed -$659K – 1902
2020
Q4 		$659K Buy
+3,240
New +$626K 0.02% 848
2019
Q3 		– Sell
-564
Closed -$199K – 1382
2019
Q2 		$199K Buy
+564
New +$222K 0.01% 975

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Paul Tudor Jones's QTTB Position: Q1 2024 in Review

Paul Tudor Jones sold out of Q32 Bio (QTTB) in Q1 2024, closing a stake of 6,424 shares — an estimated $70.3K sold.

Paul Tudor Jones first reported a position in QTTB in Q2 2019 and held it in 12 quarters. The position peaked at $939K in Q2 2021. 39 funds tracked by Wall St. Rank hold QTTB as of Q1 2024.

  • Paul Tudor Jones reported no remaining Q32 Bio position as of Q1 2024 after selling out during the quarter.
  • Paul Tudor Jones sold 6,424 Q32 Bio shares in Q1 2024, an estimated $70.3K.
  • Paul Tudor Jones first reported a position in Q32 Bio in Q2 2019 and held it in 12 quarters.
  • Paul Tudor Jones's Q32 Bio position peaked at $939K in Q2 2021.
  • 39 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2024.

Based on Tudor Investment Corp's 13F filing for Q1 2024, filed 15 May 2024.